Defining high-fat-diet rat models: metabolic and molecular effects of different fat types Authors: R Buettner, K G Parhofer, M Woenckhaus, C E Wrede, L A Kunz-Schughart, J Schölmerich and L C Bollheimer
Developmental origins of disease and determinants of chromatin structure: maternal diet modifies the primate fetal epigenome Authors: Kjersti M Aagaard-Tillery, Kevin Grove, Jacalyn Bishop, Xingrao Ke, Qi Fu, Robert McKnight and Robert H Lane
Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) α and δ and PPAR coactivator 1α in human skeletal muscle, but not lipid regulatory genes Authors: M J Watt, R J Southgate, A G Holmes and M A Febbraio
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease Authors: Thomas Svava Nielsen, Niels Jessen, Jens Otto L Jørgensen, Niels Møller and Sten Lund
Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis Authors: Fadil M Hannan, Valerie N Babinsky and Rajesh V Thakker
Metformin in cancer: translational challenges Authors: Ryan J O Dowling, Saroj Niraula, Vuk Stambolic and Pamela J Goodwin
Endocrine disruptive chemicals: mechanisms of action and involvement in metabolic disorders Authors: Elin Swedenborg, Joëlle Rüegg, Sari Mäkelä and Ingemar Pongratz
FGF9 inhibits browning program of white adipocytes and associates with human obesity Authors: Yingkai Sun, Rui Wang, Shaoqian Zhao, Wen Li, Wen Liu, Lingyun Tang, Zhugang Wang, Weiqing Wang, Ruixin Liu, Guang Ning, Jiqiu Wang and Jie Hong
Novel cancer therapies and their association with diabetes Authors: Afreen Idris Shariff, Sohail Syed, Rebecca A Shelby, Jeremy Force, Jeffrey Melson Clarke, David D’Alessio and Leonor Corsino
Novel therapies in osteoporosis: PTH-related peptide analogs and inhibitors of sclerostin Authors: Tilman D Rachner, Lorenz C Hofbauer, Andy Göbel and Elena Tsourdi
